Riskpilot← Back to searchSign inGet full accessResMed Finland Oy
OYActiveY-tunnus 1786754-0Hatsinanpuisto 8Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200217 employees
Revenue 2024
EUR 38,6M
+13% vs 2023
EBITDA margin
4.9%
+21% vs 2023
Equity ratio
63.3%
Financial strength
Net profit 2024
EUR 1,9M
+42% vs 2023
| Revenue | EUR 38,6M | +13% |
| EBITDA | EUR 1,9M | +21% |
| Net profit | EUR 1,9M | +42% |
| Total assets | EUR 18,2M | +4% |
| Equity | EUR 11,5M | +19% |
| Employees | 17 | — |
Legal name
ResMed Finland Oy
Y-tunnus number
1786754-0
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. syyskuuta 2002
Share capital
EUR 80 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Föremålet för bolagets verksamhet är att bedriva tillverkning, försäljning och distribution av medicinsk utrustning samt därmed förenlig verksamhet.
Address
Hatsinanpuisto 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 28 846 | 31 833 | 31 747 | 34 278 | 38 595 |
| Staff expenses | −1 937 | −1 775 | −1 987 | −2 179 | −2 376 |
| EBITDA | 1 280 | 1 452 | 1 402 | 1 564 | 1 894 |
| Depreciation & amort. | −79 | −120 | −137 | −118 | −118 |
| EBIT | 1 201 | 1 332 | 1 265 | 1 446 | 1 777 |
| Net financials | 40 | 44 | 48 | 255 | 539 |
| Profit before tax | 1 240 | 1 376 | 1 313 | 1 667 | 2 320 |
| Tax | 255 | 268 | 282 | 352 | 452 |
| Net profit | 986 | 1 108 | 1 031 | 1 316 | 1 868 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 001 | 16 538 | 17 222 | 17 488 | 18 184 |
| Equity | 6 197 | 7 306 | 8 324 | 9 640 | 11 508 |
| Long-term debt | 311 | 230 | 501 | 905 | 611 |
| Short-term debt | 8 185 | 8 628 | 8 398 | 6 943 | 6 065 |
| Total debt | 8 804 | 9 231 | 8 898 | 7 848 | 6 677 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20202024
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20202024
Return on equity
16.2%
This company
18.4%
Market median
+12% vs market
20202024
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20202024
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
20202024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA Chief Executive Officer | Chief Executive Officer | 2002 |
| Former (2) | ||
LV | Audit | 2021 – 2023 |
KJ Audit | Audit | 2013 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2023 | |
| Board of Directors | 2018 | |
| Former (1) | ||
| Chairperson | 2018 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ResMed Finland Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jussi Antero Vuorela | Chief Executive Officer | 0 companies |
| Lassi Valtteri Liimatainen | Audit | 0 companies |
| Kim Johan Järvi | Audit | 0 companies |
| Michael James Rider | Chairperson | 0 companies |
| Nigel Wayne Robinson | Board of Directors | 0 companies |
| David Brian Pendarvis | Chairperson | 0 companies |